You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High-Throughput Nucleotide Sequencing

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Contribution of New Generation Oxford Nanopore-type

Unknown status
  • Neuro-Degenerative Disease
  • Subject carrying an amplification of nucleotide repeats in one of the following 9 genes FMR1, DMPK, ZNF9, SCA2, JPH3, HD, FXN, C9ORF72, RFC1
  • (no location specified)
Nov 3, 2020

Lumbar Degenerative Diseases, Gene Product Sequence Variation Trial in Jinan (Lumbar disc herniation, Lumbar spinal stenosis)

Not yet recruiting
  • Lumbar Degenerative Diseases
  • Gene Product Sequence Variation
  • Lumbar disc herniation
  • Lumbar spinal stenosis
  • Jinan, Shandong, China
    Hao-Xuan Zhang
Oct 4, 2023

Precision Cancer Medicine for Advanced Cancer Through

Recruiting
  • Cancer
  • Biospecimen collection
  • Columbus, Ohio
    Ohio State University Wexner Medical Center
Feb 15, 2022

Human Papillomavirus Trial in Toulouse (Smear)

Recruiting
  • Human Papillomavirus
  • Smear
  • Toulouse, France
    CHU Toulouse
Jul 18, 2022

" Fast " Pangenomic High Throughput Sequencing Analysis in

Recruiting
  • Prenatal
  • Genome-wide High Throughput Sequencing
  • Invasive fetal sampling, blood sampling of mother and father
  • +5 more
  • Dijon, France
    CHU Dijon Bourgogne
Jun 20, 2022

Benign/Malignant Pulmonary Nodule Classification Based on

Recruiting
  • Pulmonary Nodule, Solitary
  • Whole-genome Methylation Sequencing
  • Whole-genome Methylation Sequencing(GM-seq)
  • Beijing, Beijing, China
  • +1 more
Jun 8, 2022

Clinical Implication of Retinitis Pigmentosa Molecular

Recruiting
  • Retinitis Pigmentosa
    • Dijon, France
    • +3 more
    Apr 19, 2022

    Infection Trial (PMseqTM high-throughput sequencing technology)

    Not yet recruiting
    • Infection
    • PMseqTM high-throughput sequencing technology
    • (no location specified)
    Aug 2, 2021

    Intellectual Disability, Rubinstein-Taybi Syndrome, Cystic Fibrosis Trial in Bordeaux (Ex-vivo approach concerning 25 patients,

    Not yet recruiting
    • Intellectual Disability
    • +6 more
    • Ex-vivo approach concerning 25 patients
    • In-vitro approach concerning 25 patients
    • Bordeaux, France
      Hopital Pellegrin
    Jan 23, 2023

    Development Disorders Trial in Dijon, Lyon, Paris (interviews with a psychologist)

    Completed
    • Development Disorders
    • interviews with a psychologist
    • Dijon, France
    • +2 more
    Sep 13, 2022

    Molecular Study and Precision Medicine for Colorectal Cancer

    Not yet recruiting
    • Advanced Colorectal Carcinoma
    • Recurrent Colorectal Carcinoma
    • Molecular Profiling & drug testing in tumor organoids and PDXs
    • Wuhan, Hubei, China
      Wuhan Union Hospital, China
    May 30, 2023

    Contribution of High Throughput RNA Sequencing Combined With

    Completed
    • Patients With Intellectual Disabilities Without an Obvious Clinical Diagnosis
    • Patients With Normal Array CGH and Previous Negative Genetic Investigations (WES-solo or WES-trio)
    • Patient blood sampling
    • Parents blood sampling
    • Dijon, France
      Chu Dijon Bourgogne
    Sep 30, 2021

    Molecular and/or Pathophysiological Bases of Developmental

    Recruiting
    • Developmental Anomalies
    • Blood sample
    • high-throughput sequencing
    • Dijon, France
      Chu Dijon Bourogne
    May 16, 2022

    Different High-throughput Sequencing Strategies in Diagnosis of

    Recruiting
    • Intellectual Deficiency
    • blood samples from children
    • blood samples from parents
    • Dijon, France
      Chu Dijon Bourogne
    Aug 3, 2021

    Soft Tissue Sarcoma Trial in France (drug, combination product, other)

    Recruiting
    • Soft Tissue Sarcoma
    • Bordeaux, France
    • +17 more
    Oct 4, 2022

    Precision Medicine for Every Child With Cancer

    Recruiting
    • Childhood Cancer
    • +5 more
    • Whole Genome Sequencing
    • +6 more
    • Adelaide, Australia
    • +8 more
    Jan 24, 2023

    Using Next Generation Sequencing on Biological Samples to

    Completed
    • Holoprosencephaly
    • NGS
    • Rennes, France
      CHU Rennes
    Dec 6, 2021

    Invasive Markers of Staphylococcus Epidermidis

    Completed
    • Staphylococcus Epidermidis Positive Blood Culture
    • high-throughput sequencing
    • Paris, Ile De France, France
      Hôpital Necker Enfants Malades
    Dec 9, 2021

    Kidney Transplantation Trial (High throughput DNA and RNA sequencing)

    Completed
    • Kidney Transplantation
    • High throughput DNA and RNA sequencing
    • (no location specified)
    Nov 10, 2021

    Breast Cancer, Colo-rectal Cancer Trial in Avignon (Blood samples)

    Recruiting
    • Breast Cancer
    • Colo-rectal Cancer
    • Blood samples
    • Avignon, France
      Centre Hospitalier Henri Duffaut
    Jan 8, 2021

    Clinical Value of Metagenomic Sequencing in Neonatal Sepsis

    Recruiting
    • Neonatal Sepsis
      • Shanghai, China
        Children Hospital of Fudan University
      Jun 13, 2022

      Clinical Outcome in Patients With Syringomyelia(COPSM)

      Recruiting
      • Syringomyelia/Hydromyelia
      • high throughput sequencing and electromyography
      • Beijing, Beijing, China
        Xuanwu Hospital
      Jun 6, 2021

      "Rapid" High Throughput Genome Sequencing Analysis in Diagnostic

      Recruiting
      • Developmental Anomalies
      • blood sample
      • genome sequencing
      • Dijon, France
        Chu Dijon Bourgogne
      Sep 9, 2020

      PRediction Of Five Usual Tumors Using Blood Test for Risk

      Not yet recruiting
      • Neoplasms
      • Cancer
      • Multi-cancer early detection test
      • Guangzhou, Guangdong, China
        The Sixth Affiliated Hospital of Sun Yat-sen University
      May 16, 2023

      Next-Generation-Sequencing Trial (Molecular genetic diagnostic)

      Not yet recruiting
      • Next-Generation-Sequencing
      • Molecular genetic diagnostic
      • (no location specified)
      May 12, 2023